After months of silence, biotech companies are finally stepping back onto Wall Street. LB Pharma is leading the charge, raising cash to push its new schizophrenia drug through final testing. Why does this matter? If you’re into investing, it’s a sign that the market might be warming up again. For everyone else, it could mean new treatments are on the horizon—and maybe more buzz in your portfolio soon. #Business #Industry #biotech